| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Fixed assets, net | 78,083 | |||
| Right-of-use asset | 35,640 | |||
| Total non-current assets | 113,723 | |||
| Prepaids and other current assets | 40,156 | |||
| Deferred offering costs | 153,032 | |||
| Cash | 147,192 | |||
| Total current assets | 340,380 | |||
| Total assets | 454,103 | |||
| Lease liability - long term | 0 | |||
| Total non-current liabilities | 0 | |||
| Lease liability current | 36,545 | |||
| Current maturities of notes payable | 275,733 | |||
| Current maturities of convertible notes payable, net of discounts | 1,208,235 | |||
| Accrued expenses-Related Party | 59,901 | |||
| Accrued expenses-Nonrelated Party | 223,034 | |||
| Accounts payable | 383,256 | |||
| Total current liabilities | 2,186,704 | |||
| Total liabilities | 2,186,704 | |||
| Accumulated deficit | -23,090,912 | |||
| Preferred stock, value-Series DPreferred Stock | 0 | |||
| Preferred stock, value-Series CPreferred Stock | 1 | |||
| Preferred stock, value-Series AConvertible Preferred Stock | 1,048 | |||
| Common stock, 0.001 par value, 880,000,000 shares authorized 145,121,825 and 123,046,825 shares issued and outstanding as of june 30, 2025 and september 30, 2024, respectively | 145,121 | |||
| Additional paid-in capital | 20,878,541 | |||
| Total stockholders deficit | -2,066,201 | |||
| Series b convertible preferred stock, 0.001 par value, 1,500,000 shares authorized 333,600 shares issued and outstanding as of june 30, 2025 and september 30, 2024 | 333,600 | |||
| Total liabilities and stockholders deficit | 454,103 | |||
Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (FUNI)